VRCA NASDAQ
Verrica Pharmaceuticals Inc.
1W: +0.2%
1M: -18.7%
3M: -28.6%
YTD: -47.2%
1Y: -1.4%
3Y: -88.5%
5Y: -96.2%
$4.38
-0.14 (-2.99%)
Weekly Expected Move ±8.2%
$4
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2024-05-15
Earliest Filing
2025-11-24
Latest Filing
partner: 2
investor: 1
Counterparties (Filed by VRCA)
3 relationshipsCompanies named in VRCA's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Caligan Partners LP | — | investor | Institutional investor purchasing common stock and warrants, and appointing a Class I Board member. | 2025-11-24 | View |
| Torii Pharmaceutical Co., Ltd. | — | partner | Collaboration and License Agreement amendment involving milestone payments, cost sharing for Phase 3 trial, and technolo | 2025-07-01 | View |
| Torii Pharmaceutical Co., Ltd. | — | partner | Amendment to collaboration and license agreement for Phase 3 clinical trial of YCANTH (VP-102) | 2024-05-15 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-09 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-03-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-30 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-24 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View | |
| 2025-07-30 | Notice of Delisting or Transfer | View | |
| 2025-07-23 | Material Modification to Rights of Security Holders; Financial Statements and Exhibits | View | |
| 2025-07-01 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-06-12 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-06-05 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-25 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-02 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-21 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-01-30 | Notice of Delisting or Transfer | View | |
| 2024-12-09 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR